AGILE THERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Agile Therapeutics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2014 to Q2 2024.
  • Agile Therapeutics Inc Entity Common Stock, Shares Outstanding for the quarter ending August 12, 2024 was 6.9M shares, a 258% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 6.9M +4.98M +258% Aug 12, 2024 10-Q 2024-08-12
Q1 2024 6.86M -39.7M -85.3% Mar 27, 2024 10-K 2024-03-28
Q3 2023 2.51M -38.1M -93.8% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 1.93M -37.1M -95.1% Aug 7, 2023 10-Q 2023-08-09
Q1 2023 46.5M -88.1M -65.4% Mar 14, 2023 10-K 2023-03-23
Q3 2022 40.6M -80.8M -66.5% Nov 4, 2022 10-Q 2022-11-07
Q2 2022 39M -54M -58% Aug 10, 2022 10-Q 2022-08-11
Q1 2022 135M +46.4M +52.5% Mar 25, 2022 10-K 2022-03-30
Q3 2021 121M +34M +38.8% Oct 29, 2021 10-Q/A 2021-12-30
Q2 2021 93M +5.7M +6.53% Jul 23, 2021 10-Q 2021-07-26
Q1 2021 88.3M +1.05M +1.21% Apr 30, 2021 10-Q 2021-05-04
Q3 2020 87.4M +28.1M +47.4% Nov 9, 2020 10-Q 2020-11-12
Q2 2020 87.3M +42.5M +95% Aug 7, 2020 10-Q 2020-08-11
Q1 2020 87.2M +44M +102% May 1, 2020 10-Q 2020-05-05
Q3 2019 59.3M +24.9M +72.5% Oct 28, 2019 10-Q 2019-10-28
Q2 2019 44.8M +10.4M +30.2% Jul 31, 2019 10-Q 2019-08-01
Q1 2019 43.2M +8.97M +26.2% Mar 11, 2019 10-K 2019-03-12
Q3 2018 34.4M +191K +0.56% Nov 1, 2018 10-Q 2018-11-02
Q2 2018 34.4M +5.57M +19.3% Aug 2, 2018 10-Q 2018-08-03
Q1 2018 34.2M +5.47M +19% Mar 9, 2018 10-K 2018-03-12
Q3 2017 34.2M +5.43M +18.9% Nov 3, 2017 10-Q 2017-11-06
Q2 2017 28.8M +53.7K +0.19% Jul 27, 2017 10-Q 2017-07-28
Q1 2017 28.8M +38.8K +0.14% Mar 10, 2017 10-K 2017-03-15
Q3 2016 28.8M +6.47M +29% Nov 4, 2016 10-Q 2016-11-07
Q2 2016 28.8M +6.48M +29.1% Aug 5, 2016 10-Q 2016-08-08
Q1 2016 28.7M +6.58M +29.7% Mar 4, 2016 10-K 2016-03-09
Q3 2015 22.3M +3.7M +19.9% Nov 9, 2015 10-Q 2015-11-09
Q2 2015 22.3M +3.68M +19.8% Aug 12, 2015 10-Q 2015-08-13
Q1 2015 22.2M Mar 16, 2015 10-K 2015-03-26
Q3 2014 18.6M Nov 13, 2014 10-Q 2014-11-13
Q2 2014 18.6M Aug 13, 2014 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.